To view more episodes, subscribe, and ask your questions, go to mikereinold.com/askmikereinold
sthrn labs does not reproduce, excerpt, or summarize article content
A deficiency can lead to weakness that hampers diet plans
Preclinical and clinical studies have demonstrated its efficacy in reducing body weight both as a monotherapy and in combination with GLP-1 receptor agonists such as semaglutide, highlighting its potential as a next-generation therapeutic agent for obesity and metabolic syndrome management
Tracking details are sent after fulfillment, and support can help with order or carrier questions
The referral destination depends on the accompanying findings: liver findings may point to hepatology or gastroenterology, significant kidney disease to nephrology, abnormal counts or smear findings to hematology, and cancer concern to oncology